AAREY DRUGS & PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.46 INR | +2.99% |
|
+14.37% | +9.76% |
| Sales 2022 | 4.93B 59.07M 81.04M | Sales 2023 | 4.19B 50.22M 68.89M | Capitalization | 601M 7.2M 9.88M |
|---|---|---|---|---|---|
| Net income 2022 | 65M 779K 1.07M | Net income 2023 | 37M 443K 608K | EV / Sales 2022 | 0.24 x |
| Net Debt 2022 | 140M 1.67M 2.3M | Net Debt 2023 | 366M 4.39M 6.02M | EV / Sales 2023 | 0.23 x |
| P/E ratio 2022 |
15.2
x | P/E ratio 2023 |
15.9
x | Employees | 132 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.57% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.99% | ||
| 1 week | +14.37% | ||
| Current month | +24.13% | ||
| 1 month | +18.23% | ||
| 3 months | +1.22% | ||
| 6 months | +32.36% | ||
| Current year | +9.76% |
1 week
48.75
56.50
1 month
43.5156.50
Current year
37.0068.00
1 year
27.4168.00
3 years
21.9068.00
5 years
11.5068.00
10 years
10.00143.95
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 04-08-01 | |
| Director of Finance/CFO | - | 21-01-03 | |
| Compliance Officer | - | 20-01-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 04-08-01 | |
| Director/Board Member | 66 | 04-12-01 | |
| Director/Board Member | 55 | 08-06-01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 55.46 | +2.99% | 36 023 |
| 24-04-30 | 53.85 | +1.89% | 1,007 |
| 24-04-29 | 52.85 | -3.77% | 9,034 |
| 24-04-26 | 54.92 | +2.75% | 29,894 |
| 24-04-25 | 53.45 | +4.99% | 38,892 |
Delayed Quote Bombay S.E., May 02, 2024 at 06:00 am
More quotes
Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxaphylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Chlorinated Solvents, Industrial Intermediates, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.
Sector
Pharmaceuticals
Calendar
2024-05-26
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +9.76% | 18.1M | |
| +31.82% | 699B | |
| +25.67% | 571B | |
| -4.17% | 364B | |
| +18.49% | 326B | |
| +2.68% | 286B | |
| +14.47% | 236B | |
| +4.61% | 198B | |
| -12.23% | 194B | |
| -3.52% | 154B |
- Stock Market
- Equities
- AAREYDRUGS Stock
